Matriptase/ST14 Catalytic Domain Protein, Human
Based on 1 Customer Validation
The Matriptase/ST14 catalytic domain protein originates from epithelial cells, forms a complex with HAI-1, and is activated by sphingosine-1-phosphate. It cleaves and activates hepatocyte growth factor/scatter factor and urokinase plasminogen activator, suggesting its role as an activator of other proteases and potential growth factors. Matriptase/ST14 Catalytic Domain Protein, Human is the recombinant human-derived Matriptase/ST14 Catalytic Domain protein, expressed by E. coli, with tag free.
- Species: Human
- Source: E. coli
-
Storage:Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Biological Activity
Description
The Matriptase/ST14 catalytic domain protein originates from epithelial cells, forms a complex with HAI-1, and is activated by sphingosine-1-phosphate. It cleaves and activates hepatocyte growth factor/scatter factor and urokinase plasminogen activator, suggesting its role as an activator of other proteases and potential growth factors. Matriptase/ST14 Catalytic Domain Protein, Human is the recombinant human-derived Matriptase/ST14 Catalytic Domain protein, expressed by E. coli, with tag free.
Background
The Matriptase/ST14 Catalytic Domain Protein is an integral membrane serine protease derived from epithelial cells. It forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is activated by sphingosine 1-phosphate. This protease has been demonstrated to cleave and activate hepatocyte growth factor/scattering factor, as well as urokinase plasminogen activator, suggesting its role as an activator for other proteases and latent growth factors on the epithelial membrane. The expression of this protease has been linked to breast, colon, prostate, and ovarian tumors, indicating its involvement in cancer invasion and metastasis. It exhibits broad expression in colon (RPKM 103.0), small intestine (RPKM 72.7), and 15 other tissues.
Verified Bioactivity
Measured by its ability to cleave the fluorogenic peptide substrate Boc-QAR-AMC. The specific activity is >15,000 pmol/min/μg.
Technical Parameters
-
Species Human
-
Source E. coli
-
Tag Tag Free
-
Accession
NP_068813 (G596-V855)
-
Gene ID6768
-
Molecular Construction
-
N-term
-
Matriptase (G596-V855)
Accession # NP_068813 -
C-term
-
-
Protein Length
Partial
-
Synonyms
ST14; Matriptase; Prev. PRSS14; TADG15; MT-SP1; Suppression Of Tumorigenicity 14 (Colon Carcinoma, Matriptase, Epithin); SNC19; Tumor Associated Differentially Expressed Gene 15 Protein; TMPRSS14; Tumor-Associated Differentially-Expressed Gene 15 Protein; CAP3; Suppression Of Tumorigenicity 14; HAI; Channel–Activating Protein 3; Suppression Of Tumorigenicity 14 (Colon Carcinoma); Channel-Activating Protein 3; Suppressor Of Tumorigenicity 14 Protein; ST14 Protein; Membrane-Type Serine Protease 1; Epithin; Serine Protease TADG-15; ARCI11; Serine Protease 14; MTSP1; ST14 Transmembrane Serine Protease Matriptase; Prostamin
-
AA Sequence
GSDEKDCDCGLRSFTRQARVVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV
-
Predicted Molecular Mass
30.6 kDa
-
Molecular Weight
Approximately 27-28 kDa, based on SDS-PAGE under reducing conditions.
-
Purity
≥ 90%, as determined by reducing SDS-PAGE.
Product Properties
Solution
Supplied as 0.22 μm filtered solution of 50 mM Tris, 150 mM NaCl, 10% trehalose, pH 7.5 with 50% glycerol as protectant.
Note: For SPR assay, please replace the buffer. Primary amine components (e.g., Tris, imidazole) can affect protein-coupled chips.
/
Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Shipping with dry ice.
Documentation
-
Data Sheet (236 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)